The European Patent Office (EPO) has published patent application EP4048786A1, titled "CHIMERIC POLYPEPTIDES AND USES THEREOF." This publication, dated March 11, 2026, details inventions related to chimeric polypeptides. The applicants listed are Genethon, Universite d'Evry Val d'Essonne, INSERM (Institut National de la Santé et de la Recherche Médicale), and SORBONNE UNIVERSITE. The patent application covers various designated states within the European Union and beyond.

This patent publication is primarily an informational notice regarding intellectual property. It does not impose new compliance obligations or penalties on regulated entities. Companies operating in the biotechnology and pharmaceutical sectors, particularly those involved in polypeptide research and development, may wish to review this publication for competitive intelligence or potential licensing opportunities. No immediate action is required from a compliance perspective.